Syngenta and Evogene to Collaborate on Soybean Nematode Resistance
News Jul 03, 2009
Syngenta Biotechnology, Inc. announced that it has entered into a collaboration agreement with Evogene, Ltd., focusing on identifying plant genes related to soybean nematode resistance. Under the agreement, Syngenta will receive exclusive licensing rights to candidate genes discovered by Evogene for use in soybean.
"Syngenta is a leader in advanced breeding to bring our grower customers the best choices to protect yield against soybean pests," stated Roger Kemble, Head Syngenta Crop Genetics Research. "This collaboration complements our in-house trait discovery program, creating new sources of genes for biotech traits to strengthen our current offering."
Under this agreement, Evogene will provide Syngenta with candidate genes discovered by Evogene's proprietary computational gene discovery technology, the 'ATHLETE'. Syngenta will evaluate candidate genes in its soybean research and development program. Syngenta may commercialize improved soybean seeds developed through this collaboration.
"We are very pleased by this collaboration with Syngenta and we look forward to working with the Syngenta team on this key trait for soybean," stated Ofer Haviv, Evogene's President and CEO. "Plant pest protection traits, such as nematode resistance, have a strong impact on farm productivity hence Evogene intends to expand use of its predictive technologies for gene discovery in this field," Mr. Haviv concluded.
Specific details of the agreement were not disclosed.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE